- Home
- AQST vs LANV Comparison
AQST vs LANV Comparison
Compare AQST & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- LANV
- Stock Information
- Founded
- AQST 2004
- LANV 2015
- Country
- AQST United States
- LANV China
- Employees
- AQST N/A
- LANV N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- AQST Health Care
- LANV Finance
- Exchange
- AQST Nasdaq
- LANV Nasdaq
- Market Cap
- AQST 272.9M
- LANV 258.1M
- IPO Year
- AQST 2018
- LANV N/A
- Fundamental
- Price
- AQST $3.40
- LANV $2.20
- Analyst Decision
- AQST Strong Buy
- LANV
- Analyst Count
- AQST 6
- LANV 0
- Target Price
- AQST $10.67
- LANV N/A
- AVG Volume (30 Days)
- AQST 1.6M
- LANV 39.1K
- Earning Date
- AQST 08-05-2025
- LANV 08-25-2025
- Dividend Yield
- AQST N/A
- LANV N/A
- EPS Growth
- AQST N/A
- LANV N/A
- EPS
- AQST N/A
- LANV N/A
- Revenue
- AQST $54,228,000.00
- LANV $340,211,202.00
- Revenue This Year
- AQST N/A
- LANV $11.74
- Revenue Next Year
- AQST $45.71
- LANV $11.11
- P/E Ratio
- AQST N/A
- LANV N/A
- Revenue Growth
- AQST 5.29
- LANV N/A
- 52 Week Low
- AQST $2.12
- LANV $0.91
- 52 Week High
- AQST $5.80
- LANV $2.69
- Technical
- Relative Strength Index (RSI)
- AQST 58.21
- LANV 53.77
- Support Level
- AQST $3.13
- LANV $2.00
- Resistance Level
- AQST $3.33
- LANV $2.51
- Average True Range (ATR)
- AQST 0.21
- LANV 0.14
- MACD
- AQST -0.03
- LANV 0.01
- Stochastic Oscillator
- AQST 46.94
- LANV 39.22
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.